0.35Open0.42Pre Close118 Volume126 Open Interest70.00Strike Price2.24KTurnover380.32%IV0.57%PremiumNov 1, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.2211Delta0.7563Gamma1407.00Leverage Ratio-74.8133Theta0.0000Rho-311.08Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet